could recombinant IVIG be a future consideration for GTCB? not sure how their Mab capability could be adapted to polyclonal Abs, but seems plausible IVIG is hugely expensive now and from pooled plasma so sounds kind of ideal for transgenics from cost/safety prespective just a thought..